Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Jun;107(1):27-30.
doi: 10.1007/s00436-010-1828-8. Epub 2010 Mar 23.

Anthelmintic activity of KSI-4088 against Caenorhabditis elegans

Affiliations
Comparative Study

Anthelmintic activity of KSI-4088 against Caenorhabditis elegans

Kusuma Kaewintajuk et al. Parasitol Res. 2010 Jun.

Abstract

Anthelmintic resistance is a serious global problem because of the worldwide spread of resistant nematodes in animals and humans. This has triggered increasing investment in research for new anthelmintics. Over the past decade, Caenorhabditis elegans has become a popular model organism for parasitic nematode research, and many examples have been published to illustrate its use. In this study, we investigated the effect of KSI-4088 on the egg hatching, larval development, and migration of the nematode worm C. elegans compared with ivermectin and levamisole (well-known anthelmintic drugs). KSI-4088 demonstrated anthelmintic activity on all assays of C. elegans. The anthelmintic activity of KSI-4088 on egg hatching and larval development showed especially strong activity, but assays showed that ivermectin and levamisole had no effects on C. elegans. In addition, KSI-4088 was capable of producing a change in the timing of the development of the worms at the L1-L3 and L4 stage. Also, we demonstrate that C. elegans L3-4 are more sensitive than adults to KSI-4088 in assay of migration. Our results indicate that KSI-4088 is an active anthelmintic compound that should be further investigated with the aim of developing a potent drug against nematodes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Int J Parasitol. 1994 Aug;24(5):671-6 - PubMed
    1. Vet Parasitol. 2003 Jul 25;115(2):167-84 - PubMed
    1. Br Med Bull. 1998;54(2):421-32 - PubMed
    1. Int J Parasitol. 2007 May;37(6):627-36 - PubMed
    1. Int J Parasitol. 2009 Jan;39(2):213-20 - PubMed

Publication types

LinkOut - more resources